New Anti-Anginal Drugs: Ranolazine

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 13, Iss. 1, 2015-01 ,pp. : 14-20

Bentham Science Publishers

Access to resources Recommend Favorite

Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 13, Iss. 1, 2015-01 ,pp. : 21-24

Bentham Science Publishers

Access to resources Recommend Favorite

Five-year cardiovascular and all-cause mortality, and myocardial infarction in all subjects referred for exercise testing in two Danish counties

By Niemann Troels   Labouriau Rodrigo   Toft Sørensen Henrik   Thorsgaard Niels   Toftegaard Nielsen Torsten  

Scandinavian Cardiovascular Journal, Vol. 38, Iss. 3, 2004-06 ,pp. : 137-142

Informa Healthcare

Access to resources Recommend Favorite

Use of lung function tests in asthmatic children is associated with lower risk of hospitalization. A Danish population-based follow-up study

By Moth Grete   Schiotz Peter Oluf   Parner Erik   Vedsted Peter  

Journal of Asthma, Vol. 47, Iss. 9, 2010-11 ,pp. : 1022-1030

Informa Healthcare

Access to resources Recommend Favorite

The impact of diabetes on prescription drug costs: the population-based Turin study

By Bruno G.   Karaghiosoff L.   Merletti F.   Costa G.   Maria M.   Panero F.   Segre O.   Cavallo-Perin P.   Gnavi R.  

Diabetologia, Vol. 51, Iss. 5, 2008-05 ,pp. : 795-801

Springer Publishing Company

Access to resources Recommend Favorite